Media center
Comunicato stampa “Farma Industria Ticino and Credit Suisse Award for best student”, mercoledì 18 settembre 2019
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma (MF-CTCL) treatment at the 49th European Society for Dermatological Research Annual Meeting 2019
Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology
Augusto Mitidieri awarded as “Most Innovative Pharmaceutical CEO – Europe 2019”
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China
APR presents new data at SSIEM Annual Symposium showing benefits of PKU GOLIKE® in PKU management
Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
Progetto Talenti
Linkedin